Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Neutropenia 1Neoplasms 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Specimen Handling 60Magnetic Resonance Spectroscopy 43Carboplatin 33Cyclophosphamide 31Gemcitabine 28Biopsy 26Cisplatin 25pembrolizumab 24Bevacizumab 24Paclitaxel 23Injections 22Standard of Care 21Radiotherapy 21Drug Therapy 21Capecitabine 21fludarabine 20venetoclax 19Oxaliplatin 19toripalimab 17Nivolumab 17Interviews as Topic 17Dexamethasone 17Blood Specimen Collection 16anlotinib 15Radiosurgery 15tislelizumab 14Azacitidine 14cemiplimab 13Pemetrexed 13Irinotecan 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Metronidazole × 90 days × Clear all
NCT07590648 2026-05-15

E-STOP2

Hospital Universitari Vall d'Hebron Research Institute

Phase 4 Not yet recruiting
136 enrolled
Classical hematologyOther hematologic neoplasm

Neoplasms, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡